Entire cohort (n = 120) | Prolonged admission (n = 50) | Discharged to home at 1 month (n = 39) | p Value | |
---|---|---|---|---|
Age, years | 55 ± 15 | 55 ± 16 | 49 ± 14 | 0.04 |
Male sex, n (%) | 71 (59%) | 29 (58%) | 23 (59%) | 1 |
Race or ethnicity, n (%) | ||||
Caucasian | 93 (77%) | 37 (74%) | 32 (82%) | 0.4 |
Other | 27 (23%) | 13 (26%) | 7 (18%) | 0.4 |
APACHE II score | 18 ± 6 | 18 ± 5 | 17 ± 6 | 0.2 |
Diagnoses | ||||
ALI/ARDS | 35 (29%) | 14 (28%) | 15 (38%) | 0.6 |
PNA/aspiration | 39 (33%) | 15 (30%) | 10 (25%) | 0.6 |
Other | 46 (38%) | 21 (42%) | 14 (35%) | 0.6 |
Intensive physical therapy treatment received | 59 (49%) | 21 (42%) | 20 (51%) | 0.7 |
Comorbidities | ||||
Cancer, n (%) | 10 (9%) | 4 (8%) | 2 (5%) | 0.6 |
Diabetes, n (%) | 27 (23%) | 13 (26%) | 6 (15%) | 0.3 |
Cirrhosis, n (%) | 16 (13%) | 8 (16%) | 3 (8%) | 0.3 |
Renal failure, n (%) | 8 (7%) | 1 (3%) | 3 (6%) | 0.7 |
HIV, n (%) | 4 (3%) | 1 (2%) | 2 (5%) | 0.6 |
Received corticosteroids, n (%) | 21 (17%) | 10 (20%) | 6 (15%) | 0.8 |
Acute care hospital LOS, days | 21 (14–33) | 30 (21–45) | 16 (12–26) | <0.0001 |
Initial discharge location | ||||
Home | 52 (43%) | 9 (18%) | 31 (79%) | <0.0001 |
Post-acute care facility | 50 (42%) | 38 (76%) | 8 (21%) | <0.0001 |
Prolonged admission at 3 months, n (%) | 15 (21%) | 14 (38%) | 1 (6%) | 0.0016 |
Prolonged admission at 6 months, n (%) | 4 (7%) | 4 (15%) | 0 | 0.034 |